Article

APA House Call: Treating Trauma Patients During the COVID-19 Pandemic

Author(s):

It might be particularly difficult for psychiatrists to treat trauma patients through telehealth means.

The 2020 American Psychiatric Association (APA) Annual Meeting was cancelled this year, with plans made to convert the world-leading psychiatry conference into a two-part virtual session and educational platform for attendees.

In lieu of regular on-site coverage, HCPLive® will be running a series of interviews, insights, and reporting on topics that frequently headline the APA meeting—featuring familiar experts.

As the coronavirus disease 2019 (COVID-19) pandemic forces virtually the entire world into social isolation, the medical field has taken to telehealth as a reasonable way to maintain non-urgent care without increasing the risk of infection.

Psychiatry might be 1 of the fields leading this charge, as many practices have already implemented some telehealth into their services.

However, some conditions may be more difficult than others to treat under these new circumstances.

In an interview with HCPLive®, David H. Jiang, MD, an assistant professor of psychiatry at Mount Sinai Morningside, explained how trauma might be particularly difficult to treat in the age of social isolation because the sense of trust is a major part of healing for trauma patients and they are often unable to regain that sense of comfort from telehealth appointments.

With that said, Jiang said psychiatrists must find a way to reach their patients and help them through this troubling time

Jiang also discussed how nurses and doctors may be more at risk for developing signs of trauma due to the unsustainable level of strain the COVID-19 virus is putting on the healthcare system and how prevalent feelings of disassociation may be for trauma patients.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
© 2024 MJH Life Sciences

All rights reserved.